| Comprehensive genomic characterization defines human glioblastoma genes and core pathways Cancer Genome Atlas Research Network Tissue source sites: Duke University ... Nature 455 (7216), 1061-1068, 2008 | 7655 | 2008 |
| Integrated proteogenomic characterization of human high-grade serous ovarian cancer H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ... Cell 166 (3), 755-765, 2016 | 1001 | 2016 |
| Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ... Cell 177 (4), 1035-1049. e19, 2019 | 671 | 2019 |
| Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial MJ Pishvaian, EM Blais, JR Brody, E Lyons, P DeArbeloa, A Hendifar, ... The Lancet Oncology 21 (4), 508-518, 2020 | 502 | 2020 |
| Rembrandt: helping personalized medicine become a reality through integrative translational research S Madhavan, JC Zenklusen, Y Kotliarov, H Sahni, HA Fine, K Buetow Molecular cancer research 7 (2), 157-167, 2009 | 470 | 2009 |
| The CPTAC data portal: a resource for cancer proteomics research NJ Edwards, M Oberti, RR Thangudu, S Cai, PB McGarvey, S Jacob, ... Journal of proteome research 14 (6), 2707-2713, 2015 | 435 | 2015 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 416 | 2020 |
| Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 247 | 2022 |
| Molecular profiling of patients with pancreatic cancer: initial results from the know your tumor initiative MJ Pishvaian, RJ Bender, D Halverson, L Rahib, AE Hendifar, S Mikhail, ... Clinical Cancer Research 24 (20), 5018-5027, 2018 | 241 | 2018 |
| Predicting new indications for approved drugs using a proteochemometric method S Dakshanamurthy, NT Issa, S Assefnia, A Seshasayee, OJ Peters, ... Journal of medicinal chemistry 55 (15), 6832-6848, 2012 | 194 | 2012 |
| The REMBRANDT study, a large collection of genomic data from brain cancer patients Y Gusev, K Bhuvaneshwar, L Song, JC Zenklusen, H Fine, S Madhavan Scientific data 5 (1), 1-9, 2018 | 181 | 2018 |
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 169 | 2022 |
| A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer AH Wagner, B Walsh, G Mayfield, D Tamborero, D Sonkin, K Krysiak, ... Nature genetics 52 (4), 448-457, 2020 | 143 | 2020 |
| Vibration based damage detection of rotor blades in a gas turbine engine S Madhavan, R Jain, C Sujatha, AS Sekhar Engineering Failure Analysis 46, 26-39, 2014 | 137 | 2014 |
| Integrated proteomic and glycoproteomic characterization of human high-grade serous ovarian carcinoma Y Hu, J Pan, P Shah, M Ao, SN Thomas, Y Liu, L Chen, M Schnaubelt, ... Cell reports 33 (3), 2020 | 130 | 2020 |
| Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection NJ Shah, G Al-Shbool, M Blackburn, M Cook, A Belouali, SV Liu, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 121 | 2019 |
| Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma D Chen, Z Zhao, Z Huang, DC Chen, XX Zhu, YZ Wang, YW Yan, S Tang, ... Bone research 6 (1), 11, 2018 | 121 | 2018 |
| Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome L Luo, P McGarvey, S Madhavan, R Kumar, Y Gusev, G Upadhyay Oncotarget 7 (10), 11165, 2016 | 109 | 2016 |
| Ly6E/K signaling to TGFβ promotes breast cancer progression, immune escape, and drug resistance M AlHossiny, L Luo, WR Frazier, N Steiner, Y Gusev, B Kallakury, ... Cancer research 76 (11), 3376-3386, 2016 | 107 | 2016 |
| Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers S Madhavan, L Bastarache, JS Brown, AJ Butte, DA Dorr, PJ Embi, ... Journal of the American Medical Informatics Association 28 (2), 393-401, 2021 | 97 | 2021 |
Yuriy GusevAssociate Professor, Innovation Center for Biomedical Informatics, Georgetown UniversityPreverjeni e-poštni naslov na georgetown.edu